Michael Starck
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 1
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Dieter Hoelzer (5 shared papers)Stefan Schwartz (5 shared papers)Andreas Viardot (3 shared papers)Albrecht Reichle (3 shared papers)Nicola Gökbuget (4 shared papers)Matthias Stelljes (2 shared papers)Joachim Beck (2 shared papers)Hubert Serve (2 shared papers)
- Journals
- Blood (2 papers)European Journal Of Haematology (2 papers)Journal of Hematology & Oncology (1 paper)Haematologica (1 paper)Scientific Reports (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Michael Starck
11 papers receiving 505 citations
Michael Starck's Hit Papers
Peers
Comparison fields: 5 of 43
- Hematology 209
- Public Health, Environmental and Occupational Health 318
- Oncology 201
- Pediatrics, Perinatology and Child Health 86
- Immunology 71
Countries citing papers authored by Michael Starck
This map shows the geographic impact of Michael Starck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Starck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Starck more than expected).
Fields of papers citing papers by Michael Starck
This network shows the impact of papers produced by Michael Starck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Starck. The network helps show where Michael Starck may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Starck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Hit paper breakdown → | 2012 | 331 |
| 2 | 2012 | 61 | |
| 3 | 2019 | 21 | |
| 4 | 2017 | 20 | |
| 5 | 2014 | 20 | |
| 6 | 2005 | 18 | |
| 7 | Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study. | 1993 | 17 |
| 8 | 2022 | 12 | |
| 9 | 2023 | 7 | |
| 10 | 2014 | 6 | |
| 11 | 2014 | 2 | |
| 12 | 2022 | 0 |
About Michael Starck
Michael Starck is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Molecular Biology and Nephrology, having authored 12 papers that have together received 515 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Renal Diseases and Glomerulopathies (2 papers), Complement system in diseases (2 papers), Acute Myeloid Leukemia Research (1 paper), Lung Cancer Research Studies (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Ultrasound and Hyperthermia Applications (1 paper). The work is most often cited by research in Hematology (209 citations), Public Health, Environmental and Occupational Health (318 citations), Oncology (201 citations), Pediatrics, Perinatology and Child Health (86 citations) and Immunology (71 citations). Michael Starck has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dieter Hoelzer, Stefan Schwartz, Andreas Viardot, Albrecht Reichle, Nicola Gökbuget, Matthias Stelljes, Joachim Beck, Hubert Serve, Knut Wendelin and Reingard Stuhlmann. Their work appears in journals such as Blood, European Journal Of Haematology, Journal of Hematology & Oncology, Haematologica and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.